FDA Statement on European Aspartame Study
My best reply (and the shortest) is to remind the reader that I have posted on SweetPoison.com the list of 92 health symptoms submitted to the FDA by medical doctors between 1986 and 1991. This list was mailed to journalist Barbara Mullarkey, who sent me a copy at that time.
Interestingly enough, this list of 92 symptoms associated with aspartame use is no longer available on the FDA Web site. The FDA no longer recognizes (or remembers) that they once acknowledged the adverse reactions as a result of aspartame use at the onset of this issue. It appears they have forgotten this list of symptoms existed within their files from 1991-1995, during which time, the list of 92 symptoms was available to the public. However, in a Dec. 2004 updated version of an FDA article about food allergies, the FDA states "To date, FDA has not determined any consistent pattern of symptoms that can be attributed to the use of aspartame, nor is the agency aware of any recent studies that clearly show safety problems."
How could the FDA forget that this list of 92 adverse health reactions existed in their files as representation of human consumer reactions to aspartame?
To your health!
Dr. Janet Starr Hull
_____________________________________
FDA Statement
FOR IMMEDIATE RELEASE
Statement
May 8, 2006 Media Inquiries:
Michael Herndon, 301-827-6242
Consumer Inquiries:
888-INFO-FDA
FDA Statement on European Aspartame Study
FDA is issuing this statement today in response to the European Food Safety Authority (EFSA) press release on its review of the long-term carcinogenicity study of aspartame conducted by the European Ramazzini Foundation (ERF).
Aspartame, a low-calorie sweetener, is composed primarily of two common amino acids, aspartic acid and phenylalanine. Each of these is also a building block for conventional foods such as protein and natural flavor molecules.
In 2005, ERF published new findings of a long-term feeding study on aspartame conducted in rats. Scientists from ERF concluded from their study that aspartame causes cancer and that current uses and consumption of the sweetener should be re-evaluated.
EFSA's review of ERF's study concluded, among other things, that on the basis of all evidence currently available to EFSA: ERF's conclusion that aspartame is a carcinogen is not supported by the data; and EFSA sees no need to further review its earlier scientific opinion on the safety of aspartame or to revise the Acceptable Daily Intake.
Upon learning of the ERF study results, FDA requested the study data from ERF to evaluate the findings. On February 28, 2006, the agency received a portion of the data requested. We are actively reviewing the data provided by ERF and will complete our review of those data as soon as possible. When FDA completes its review of the ERF study data, it will announce its conclusion.
Since it was first approved for use in the United States, the safety of aspartame has been questioned by some. To date, however, the agency has not been presented with scientific information that would support a change in our conclusions about the safety of aspartame. Those conclusions are based on a detailed review of a large body of information, including more than 100 toxicological and clinical studies regarding the sweetener's safety.
Posted on May 12, 2006 in FDA | Link
Would you like to discuss this article or provide a comment?
Visit Dr. Janet Starr Hull's Alternative Health Web Forum and discuss Aspartame toxicity information.
More About Dr. Hull: |
Aspartame Links: |
SweetPoison: |
 |
About Dr. Hull |
|
|
|
Nutrition |
|
|
|
|
Aspartame |
|
|
|
|
|
